UBS Cuts BUD APAC (01876) Target Price to HK$8.75, Maintains "Buy" Rating

Stock News
Oct 31

UBS released a research report stating that BUD APAC (01876) reported Q3 2025 revenue and adjusted EBITDA of $1.555 billion and $438 million, respectively, down 8.8% and 8.6% year-on-year. These figures were 1-3% below the bank's expectations but broadly in line with market consensus.

The bank lowered its 2025–2027 earnings forecasts for BUD APAC by 7–9%, citing persistent weakness in the Chinese market and limited visibility for Q4, with recovery now expected to be delayed until 2026.

Despite the downward revision, UBS maintained a "Buy" rating, citing premiumization trends in the home consumption channel, attractive valuation, and strong cash reserves sufficient to support stable dividends in 2025. The target price was reduced from HK$9.07 to HK$8.75.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10